Article info

Download PDFPDF
Systematic review of high-dose amikacin regimens for the treatment of Gram-negative infections based on EUCAST dosing recommendations

Authors

  1. Correspondence to Kevin J Frost, Airedale NHS Foundation Trust, Keighley BD20 6TD, UK; kevin.frost{at}nhs.net
View Full Text

Citation

Frost KJ, Hamilton RA, Hughes S, et al
Systematic review of high-dose amikacin regimens for the treatment of Gram-negative infections based on EUCAST dosing recommendations

Publication history

  • Received June 10, 2022
  • Accepted October 17, 2022
  • First published November 7, 2022.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.